Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Lactase is an enzyme replacement therapy primarily indicated for the management of lactose intolerance. It functions as a beta-galactosidase, catalyzing the hydrolysis of the disaccharide lactose into its constituent monosaccharides, glucose and galactose, which are then readily absorbed in the small intestine. In individuals with lactase deficiency, undigested lactose passes into the colon where it undergoes bacterial fermentation, resulting in symptoms such as abdominal pain, bloating, flatulence, and osmotic diarrhea. Exogenous lactase preparations, often derived from the fungus *Aspergillus oryzae* or the yeast *Kluyveromyces lactis*, are administered orally alongside dairy consumption to mitigate these symptoms. It is widely available as a dietary supplement and over-the-counter medication in various forms, including tablets, chewables, and liquid drops for infants.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on lactase.